Page last updated: 2024-08-22

uridine diphosphate galactose and Experimental Mammary Neoplasms

uridine diphosphate galactose has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endo, T; Handa, S; Hara, T; Kawakita, M; Kobata, A; Ogura, K; Rokukawa, C; Taki, T1

Other Studies

1 other study(ies) available for uridine diphosphate galactose and Experimental Mammary Neoplasms

ArticleYear
Had-1, a uridine 5'-diphosphogalactose transport-defective mutant of mouse mammary tumor cell FM3A: composition of glycolipids, cell growth inhibition by lactosylceramide, and loss of tumorigenicity.
    Cancer research, 1991, Mar-15, Volume: 51, Issue:6

    Topics: Animals; Antigens, CD; Cell Aggregation; Cell Division; Chromatography, Thin Layer; Female; Glycolipids; Glycosphingolipids; Killer Cells, Natural; Lactosylceramides; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mutation; Neoplasm Transplantation; Newcastle disease virus; Tumor Cells, Cultured; Uridine Diphosphate Galactose

1991